single source·11h ago·6 sources analyzed
FDA panel recommends mRNA flu vaccine for older adults
An FDA advisory panel has voted to recommend a new mRNA-based flu vaccine for adults aged 50 and over. This marks a significant step toward potential approval for this innovative vaccine. (sources: npr, thehill, nbcnews, ap, medicalxpress)
Image: thehill
Modern Action Briefing
The FDA advisory panel voted unanimously to recommend Moderna's mRNA influenza vaccine for older adults. This vaccine represents a new approach to flu prevention.
- The advisory panel consists of nine members who voted 9-0 in favor of the recommendation.
- The vaccine is designed for adults aged 50 and over.
- This vaccine utilizes mRNA technology, which has been used in COVID-19 vaccines.
Why it matters
The recommendation could lead to the introduction of a novel flu vaccine option for older adults.